-
-
-
-
-
-
-
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
-
-
-
-
-
-
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Repligen (RGEN)
-
-
-
-
-
-
-
Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)
-
-
-
-
-
-
-
Repligen (RGEN) Appoints Maggie A. Pax to its Board
-
-
-
-
-
-
-
Repligen Reports Second Quarter 2023 Financial ResultsĀ and Updates Full Year 2023 Financial Guidance
-
-
-
-
-
-
-
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
-
1,182,187 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

